Deformation Measurements by Echocardiography versus Late Enhancement Magnetic Resonance Imaging in Patients with Coronary Artery Disease

Login or register to view PDF.
Abstract

The aim of this article is to discuss the present and future potential of deformation imaging by echocardiography and scar visualisation by magnetic resonance imaging (MRI) in patients with coronary artery disease (CAD). The two methods are clearly different: one is concerned with function, the other with morphology. Echocardiography, with its versatility of methods and high applicability, will continue to be the workhorse in cardiac imaging of patients with CAD. Important additional information can be extracted from deformation imaging methods, especially due to the high temporal resolution in tissue Doppler. Deformation measurements in 3D images are still limited by their lower resolution compared with 2D but will continue to improve. The standardisation of image analysis and the collaboration within the echocardiographic community to conduct larger studies will be important tasks in the attempt to establish evidence for the new methods. Late enhancement MRI is a method with unique properties and will continue to be an important alternative in selected patients and settings, as well as an invaluable research tool.

Disclosure
Brage H Amundsen and Anders Thorstensen are employees of MI Lab, a research consortium of which GE Vingmed is a partner. Asbj├©rn St├©ylen has no conflicts of interest to declare.
Correspondence
Brage H Amundsen, ISB, Pb 8905, MTFS, 7491 Trondheim, Norway. E: brage.h.amundsen@ntnu.no
Received date
13 March 2012
Accepted date
03 April 2012
Citation
European Cardiology, 2012;8(2):101-4
DOI
http://dx.doi.org/10.15420/ecr.2012.8.2.101

Cardiovascular imaging is a rapidly growing area, where technological development combined with clinicians’ demand for optimal visualisation of the heart might lead us to a situation where costs are high and evidence is sparse. Applying the correct imaging modality is thus an important task in clinical practice. The aim of this article is to discuss the present and future potential of deformation imaging by echocardiography and scar imaging by magnetic resonance imaging (MRI) in two common clinical cases of coronary artery disease (CAD).

Case Studies Description
Case 1

A 55-year-old woman with a history of type 2 diabetes and hypertension is admitted two hours after the onset of severe chest pain with radiation to the neck, nausea and vomiting. The electrocardiogram (ECG) shows ST-elevation of 2–3 mm in the inferior leads, and the patient is taken directly to the catheterisation lab to undergo primary percutaneous coronary intervention (PCI) of a proximally occluded right coronary artery. No other significant lesions are found. After the procedure, she has significant dyspnoea, and an echocardiogram is performed. The left ventricle is not dilated, but ejection fraction (EF) is reduced to 35 %, with increased filling pressures. There is akinesia in the basal inferior and inferoseptal walls, with an average end-systolic longitudinal strain of 11 % in the left ventricle.

Case 2

A 73-year-old previously healthy man with a history of progressive dyspnoea over the last six months is admitted with moderate-intensity chest pain relieved by sublingual nitroglycerine and oxygen. The ECG shows ST-depression in the lateral pre-cordial leads, and troponin T is slightly elevated to 800 ng/l.

Coronary angiography shows three-vessel disease. Echocardiography shows a slightly dilated left ventricle with an end-diastolic diameter of 69 mm, an EF of 25–30 % and an average end-systolic longitudinal strain of 8 %. There is hypo- to akinesia in the lateral and anterior walls and akinesia in the apex.

Initial Assessment

These two cases illustrate two common presentations of CAD. In case 1, echocardiography can give a quick bedside answer to the clinical problem, excluding serious complications to the infarction or procedure, and guide further treatment. Final infarct size can be reliably estimated after one week, when most of the stunning will be gone.1 This could be done by visual evaluation. In case 2, the patient should undergo evaluation for revascularisation by coronary artery bypass grafting (CABG).2

In these two cases, what would be the benefit of additional imaging, and which modality should be chosen?

Myocardial Deformation Imaging by Echocardiography

Visual evaluation of wall motion is a robust and quick way to evaluate regional myocardial function, but it is semi-quantitative. With the introduction of tissue Doppler echocardiography in the 1990s, it became possible to quantify regional myocardial deformation as strain and strain rate, mainly along the long-axis of the left ventricle.3 Strain means relative deformation, with negative values indicating shortening, and strain rate means deformation rate – i.e., the velocity of deformation. Experimental studies have shown that end-systolic strain is highly influenced by afterload, while peak systolic strain rate, most often occurring during the early third of systole, is more closely linked to regional contractile function.4 However, the clinical usefulness of these methods has been limited due to problems with noise and artefacts.5 Speckle tracking echocardiography has gained more widespread acceptance, as it has been implemented with a more user-friendly interface.6 However, definite proof of added diagnostic value over conventional wall motion score (WMS) is still lacking. After being applied in 2D, the method has now been extended to 3D echocardiography.7

What Would Be the Benefit of the Method?

In case 1, myocardial deformation imaging by echocardiography can guide therapy. Angiotensin-converting enzyme inhibitors are indicated in ST-elevation myocardial infarction (STEMI) patients with EF <40 % or signs of heart failure.8 Deformation measurements are not incorporated in the guidelines, but measurements such as average left-ventricular (LV) longitudinal end-systolic strain by 2D echocardiography seem to yield prognostic value beyond EF and WMS Index (WMSI) score,9 and may give better guidance for therapy. This has also been shown for other echocardiographic measures of LV long-axis function, such as atrioventricular plane excursion and velocity.10 For the prediction of final infarct size, deformation measurements made in the acute phase have predictive value both in ST-elevation and non-ST-elevation infarctions.11,12 Interestingly, it seems that deformation measurements may predict recovery in myocardial infarction already during the first couple of days, when WMS is still altered.1 Deformation measurements also seem to have potential for selecting non-STEMI patients who might benefit from an early invasive strategy.13

In case 2, the main aim of a further imaging procedure, apart from looking for valve disease, would be to determine the extent of scar and viable myocardium in the left ventricle. Although data on hard endpoints from randomised trials are scarce, patients with depressed LV function and large proportions of viable but ischaemic myocardium are thought to benefit the most from revascularisation.14

Low-dose dobutamine stress echocardiography has been used for that purpose for many years, with visually assessed improvement in regional wall motion during dobutamine stress being regarded as a marker of viable tissue that will benefit from revascularisation.15 Interestingly, data from a recent study suggest that regional myocardial deformation measured at rest by speckle tracking echocardiography can also be used to predict the response to revascularisation.16

Late Enhancement Magnetic Resonance Imaging

MRI is an attractive imaging modality due to its non-radiation nature, its high image quality and the possibility to acquire images in any orientation. The method has gained popularity after the development of late enhancement (LE) imaging, offering the opportunity to characterise myocardial tissue in an entirely new way. By using the extracellular contrast agent gadolinium, LE MRI takes advantage of the delayed wash-in and wash-out of contrast in areas with increased extracellular volume – i.e., scar or fibrosis. In addition, an inversion-recovery sequence magnifies the difference between healthy and infarcted tissue. This gives a method with high accuracy and reproducibility.17,18

What Would Be the Benefit of the Method?

In case 1, LE MRI would be able to give similar information as echocardiography, but it would be less applicable in the acute setting. However, when applied slightly later in the acute phase, LE MRI can visualise microvascular obstruction, which is still an unsolved complication during primary PCI and a marker of increased risk of LV remodelling and heart failure.19 LE MRI can obviously also quantify infarct size – that size being significantly larger when measured during the acute phase compared with a few weeks later.17

In case 2, LE MRI would be able to visualise the presence and extent of scar and the thickness of viable myocardium in the left ventricle. The segmental extent of scar correlates to the likelihood of functional recovery after revascularisation.20

The method has gained wide acceptance, including in the latest European Society of Cardiology guidelines for revascularisation in CAD.2 In patients with substantial dysfunction, LE MRI can visualise ventricular thrombi that might be missed by echocardiography.

Which Method to Choose?

In a setting such as case 1, there is no doubt that the vast majority of STEMI patients will be adequately imaged by echocardiography. MRI might provide additional diagnostic information in selected cases, e.g., when clinical signs, symptoms and ECG suggest a STEMI but the coronary angiogram is normal.21

In a setting such as case 2, the recent substudy of the STICH (Surgical treatment for ischemic heart failure) trial questioned whether there is a benefit of viability imaging at all,22 the main question being whether surgery would be refused on the grounds of imaging alone. Although viability evaluation before revascularisation is an appealing concept pathophysiologically, there is a lack of prospective studies on hard endpoints, and most evidence comes from retrospective studies using a variety of different definitions and methods. Importantly, most of these studies were conducted before the decisive recent advances in medical therapy of heart failure. When choosing an imaging modality, the evidence is in favour of the assessment of myocardial function (using echocardiography or MRI) rather than the assessment of scar.16,23

Methodological Possibilities and Limitations
Myocardial Deformation Imaging by Echocardiography

Categorising wall motion visually is a robust and quick way of assessing regional myocardial function; it requires some experience but no post-processing. For most cardiologists, the step to quantitative deformation measurements is a large one. As computational power increases, the algorithms for calculation of strain and strain rate are increasingly complex, and the pitfalls and limitations are more difficult to understand for both clinicians and sonographers. In addition, inter-vendor differences are substantial and standardisation is difficult, probably due to technical and financial reasons.

Although strain and strain rate measurements by tissue Doppler are one-dimensional and angle-dependent, they can give important pathophysiological, diagnostic and prognostic information,24,25 especially about timing, as tissue Doppler has a high frame rate and timing is an angle-independent measurement. With speckle tracking, the different deformation components can be approximated, and this has led to a search for ‘the most sensitive direction’. From basic studies in ischaemia, we know that the different myocardial layers are tightly connected. This suggests that the accuracy of the measurement is more important than the direction in which we measure.26

In a recent paper, Becker et al.16 suggested that endocardial circumferential strain was more powerful than subepicardial measurements for predicting recovery of function after revascularisation. In a review of their experimental work with ultrasonic crystals and ischaemia, Hexeberg et al. explain why deformation in one myocardial layer can not be interpreted as representative of function in that layer.26

LV geometry can explain why endocardial deformation is larger than epicardial deformation, and consequently that endocardial changes will be numerically larger in states of reduced function in any wall layer. In light of this, one alternative interpretation of the results from Becker et al. is that inward endocardial motion can be evaluated precisely in short-axis recordings using a speckle-tracking algorithm.

Two-dimensional deformation measurements are sensitive to image positioning, and apical foreshortening is a major source of error. Three-dimensional recordings could eliminate this and should theoretically improve reproducibility. The development of 3D echocardiography has been followed by new methods of quantifying myocardial strain in such recordings. However, as the resolution, both spatially and temporally, is significantly lower in 3D compared with 2D, the need for mathematical models and smoothing has increased, as has the gap between the developing technologist and the applying cardiologist. Furthermore, patients in which the assessment of regional function and viability might be important tend to have large left ventricles, requiring large scanning sectors. This will further reduce spatial resolution and the likelihood of adequate deformation measurements. We can expect technological improvements, but a close collaboration between technologists and cardiologists is necessary to ensure that developments are going in the right direction.

Although deformation measurements by 3D echocardiography have clear limitations, the development of scanners and probes for 3D imaging has yielded technical advances that also benefit other applications. We have recently shown that frame rate in 2D tissue Doppler imaging can approach 1,000 images/second when applying 3D scanning technology, and this might allow us to resolve myocardial deformation patterns even better.27 Additionally, miniaturisation has resulted in new tools that are highly applicable and informative in a bedside setting.28

Late Enhancement Magnetic Resonance Imaging

Although the sensitivity and reproducibility of LE MRI seem superior to those of echocardiography, LE MRI has some important limitations. First, the cut-off value for prediction of viability, defined as functional response to revascularisation, is not defined. The initial landmark study by Kim et al. showed a gradual decreasing likelihood of response to revascularisation with increasing segmental infarct transmurality.20 In the large group of segments with 25–75 % infarction, the prediction of recovery was not very accurate. Second, although image quality is very good in general, the grading of segmental infarction can be challenging, especially in short-axis slices near the apex, due to partial volume effects.

Assessment using both short- and long-axis images is an advantage. Third, as mentioned above, the infarct size relative to LV mass decreases with time after an infarction. This suggests that cut-off values for viability might need adjustment over time. Finally, there is no consensus on pixel intensity cut-off for defining infarction relative to normal myocardium.29

In clinical practice, LE MRI should always be evaluated in combination with the MRI cine images. Wall thickness, which is also a well-known predictor of response to revascularisation, can be accurately measured, but wall thickening can be difficult to quantify due to the effects of trabeculae that are merging in end-systole. More advanced methods for quantifying deformation, such as tagging and strain encoded MRI (SENC) have been available for quite some time and seem promising, but temporal resolution is still somewhat lower than in echocardiography.30

Future Perspectives

Echocardiography, with its versatility of methods and high applicability, will continue to be the workhorse in cardiac imaging of patients with CAD. We should be aware of the additional information we could get from deformation methods, especially due to the high temporal resolution in tissue Doppler. Deformation measurements in 3D images are still limited by the lower resolution compared with 2D but will continue to improve. The standardisation of image analysis and the collaboration within the echocardiographic community to conduct larger studies will be important tasks in the attempt to establish evidence for the new methods. LE MRI is a method with unique properties and will continue to be an important alternative in selected patients and settings, as well as an invaluable research tool.

References
  1. Ingul CB, Malm S, Refsdal E, et al., Recovery of function after acute myocardial infarction evaluated by tissue Doppler strain and strain rate, J Am Soc Echocardiogr, 2010;23:432–8.
    Crossref | PubMed
  2. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, et al., Guidelines on myocardial revascularization, Eur Heart J, 2010;31:2501–55.
    Crossref | PubMed
  3. Heimdal A, Støylen A, Torp H, Skjaerpe T, Real-time strain rate imaging of the left ventricle by ultrasound, J Am Soc Echocardiogr, 1998;11:1013–9.
    Crossref | PubMed
  4. Ferferieva V, Van den Bergh A, Claus P, et al., The relative value of strain and strain rate for defining intrinsic myocardial function, Am J Physiol Heart Circ Physiol, 2012;302:H188–95.
    Crossref | PubMed
  5. Asbjørn Støylen, Norwegian University of Science and Technology, Strain rate imaging, Cardiac deformation imaging by ultrasound/echocardiography, Tissue Doppler and Speckle tracking, 2011. Available at: http://folk.ntnu.no/stoylen/strainrate/ (accessed 2 April 2012).
  6. Amundsen BH, Helle-Valle T, Edvardsen T, et al., Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging, J Am Coll Cardiol, 2006;47:789–93.
    Crossref | PubMed
  7. Hayat D, Kloeckner M, Nahum J, et al., Comparison of real-time three-dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease, Am J Cardiol, 2012;109:180–6.
    Crossref | PubMed
  8. Van de Werf F, Bax J, Betriu A, et al., ESC Committee for Practice Guidelines (CPG), Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology, Eur Heart J, 2008;29:2909–45.
    Crossref | PubMed
  9. Stanton T, Leano R, Marwick TH, Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring, Circ Cardiovasc Imaging, 2009;2:356–64.
    Crossref | PubMed
  10. Sveälv BG, Olofsson EL, Andersson B, Ventricular long-axis function is of major importance for long-term survival in patients with heart failure, Heart, 2008;94:284–9.
    Crossref | PubMed
  11. Vartdal T, Brunvand H, Pettersen E, et al., Early prediction of infarct size by strain Doppler echocardiography after coronary reperfusion, J Am Coll Cardiol, 2007;49:1715–21.
    Crossref | PubMed
  12. Eek C, Grenne B, Brunvand H, et al., Strain echocardiography and wall motion score index predicts final infarct size in patients with non-ST-segment-elevation myocardial infarction, Circ Cardiovasc Imaging, 2010;3:187–94.
    Crossref | PubMed
  13. Grenne B, Eek C, Sjøli B, et al., Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography, Heart, 2010;96:1550–6.
    Crossref | PubMed
  14. Wijns W, Vatner SF, Camici PG, Hibernating myocardium, N Engl J Med, 1998;339:173–81.
    Crossref | PubMed
  15. Underwood SR, Bax JJ, vom Dahl J, et al., Study Group of the European Society of Cardiology, Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology, Eur Heart J, 2004;25:815–36.
    Crossref | PubMed
  16. Becker M, Altiok E, Lente C, et al., Layer-specific analysis of myocardial function for accurate prediction of reversible ischaemic dysfunction in intermediate viability defined by contrast-enhanced MRI, Heart, 2011;97:748–56.
    Crossref | PubMed
  17. Kim RJ, Fieno DS, Parrish TB, et al., Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function, Circulation, 1999; 100:1992–2002.
    Crossref | PubMed
  18. Thiele H, Kappl MJ, Conradi S, et al., Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging, J Am Coll Cardiol, 2006;47:1641–5.
    Crossref | PubMed
  19. Ørn S, Manhenke C, Greve OJ, et al., Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention, Eur Heart J, 2009;30:1978–85.
    Crossref | PubMed
  20. Kim RJ, Wu E, Rafael A, et al., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med, 2000;343:1445–53.
    Crossref | PubMed
  21. Eitel I, Behrendt F, Schindler K, et al., Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging, Eur Heart J, 2008;29:2651–9.
    Crossref | PubMed
  22. Bonow RO, Maurer G, Lee KL, et al., STICH Trial Investigators, Myocardial viability and survival in ischemic left ventricular dysfunction, N Engl J Med, 2011;364:1617–25.
    Crossref | PubMed
  23. Wellnhofer E, Olariu A, Klein C, et al., Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery, Circulation, 2004;109:2172-4.
    Crossref | PubMed
  24. Jamal F, Strotmann J, Weidemann F, et al., Noninvasive quantification of the contractile reserve of stunned myocardium by ultrasonic strain rate and strain, Circulation, 2001;104:1059–65.
    Crossref | PubMed
  25. Bjork Ingul C, Rozis E, Slordahl SA, Marwick TH, Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography, Circulation, 2007;115:1252–9.
    Crossref | PubMed
  26. Hexeberg E, Homans DC, Bache RJ, Interpretation of systolic wall thickening. Can thickening of a discrete layer reflect fibre performance? Cardiovasc Res, 1995;29:16–21.
    Crossref | PubMed
  27. Støylen A, Aase SA, Bjaastad T, Novel High Frame Rate Sparse Tissue Doppler Imaging, Presented at: EuroEcho 2010, Copenhagen, 8–11 December 2010.
  28. Mjolstad OC, Dalen H, Graven T, et al., Routinely adding ultrasound examinations by pocket-sized ultrasound devices improves inpatient diagnostics in a medical department, Eur J Intern Med, 2012;23:18–91.
    Crossref | PubMed
  29. Flett AS, Hasleton J, Cook C, et al., Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance, JACC Cardiovasc Imaging, 2011;4:150–6.
    Crossref | PubMed
  30. Korosoglou G, Lossnitzer D, Schellberg D, et al., Strainencoded cardiac MRI as an adjunct for dobutamine stress testing: incremental value to conventional wall motion analysis, Circ Cardiovasc Imaging, 2009;2:132–40.
    Crossref | PubMed